BOT:ASX
Botanix Pharmaceuticals Ltd
၀.၀၁၇ A$
၀.၀၀%
(၀.၀၀) 1D
အောက် ၆, GMT+၁၁ ၁၆:၁၀:၂၉ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Mkt. cap
၃.၉၉ ကုဋေ
Avg. vol.
၆.၀၅ သန်း
Volume
၀.၀၀
52-wk high
၀.၁၇ A$
52-wk low
၀.၀၂ A$
EPS
-၀.၀၃ A$
Shares outstanding
၂၇၆.၁၅ ဋေ
No. of employees
၁၁
Mkt. cap
၃.၉၉ ကုဋေ
Avg. vol.
၆.၀၅ သန်း
Volume
၀.၀၀
52-wk high
၀.၁၇ A$
52-wk low
၀.၀၂ A$
EPS
-၀.၀၃ A$
Shares outstanding
၂၇၆.၁၅ ဋေ
No. of employees
၁၁
News stories
From web sources and news partners
Simply Wall Street
·
ပြီးခဲ့သည့် ၁၉ မိနစ်
What Does Ascendis Pharma (ASND) Gain From Its CNP Patent Settlement?
Yahoo Finance
·
ပြီးခဲ့သည့် ၁၈ မိနစ်
S&P 500 And Nasdaq 100 Soar To Record Highs Amid Rising Bets Of Strong Quarterly Earnings — CEG, LCID, SPCX, MRVL In Focus
Bloomberg.com
·
ပြီးခဲ့သည့် ၄၁ မိနစ်
Record Run for US Stocks to Set Tone for Asia: Markets Wrap
Investor's Business Daily
·
ပြီးခဲ့သည့် ၂ နာရီ
Dow Jones Futures: S&P 500 Hits High As Astera, GE Vernova, Arista Lead 6 AI Stock Buys
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd